NovaBridge Biosciences American Depositary Shares
NBP
20 hedge funds and large institutions have $139M invested in NovaBridge Biosciences American Depositary Shares in 2020 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 5 closing their positions.
129% more capital invested
Capital invested by funds: $60.8M → $139M (+$78.4M)
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
25% more funds holding
Funds holding: 16 → 20 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.04% less ownership
Funds ownership: 3.57% → 3.52% (-0.04%)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SLC
Snow Lake Capital
Central,
Hong Kong
|
+$3M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.43M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$1.8M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.09M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$675K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
-$7.33M |
| 2 |
NP
NS Partners
London,
United Kingdom
|
-$712K |
| 3 |
AG
Artal Group
Luxembourg
|
-$538K |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$533K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$244K |
NBP Hedge Fund Activity: Q2 2020 in Review
20 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q2 2020, worth a combined $139M — up 129% from $60.8M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new NBP positions and 5 closed out — a net gain of 4 holders — while 4 added to existing stakes and 5 trimmed.
The largest buyer was Snow Lake Capital, adding an estimated $3M. The largest seller was Sio Capital Management, cutting an estimated $7.33M.
- 20 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q2 2020, up from 16 in Q1 2020.
- Funds reported $139M of NovaBridge Biosciences American Depositary Shares stock for Q2 2020, up 129% quarter-over-quarter.
- 9 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q2 2020 and 5 closed out, a net change of +4 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q2 2020 was Snow Lake Capital, an estimated $3M added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q2 2020 was Sio Capital Management, an estimated $7.33M sold.
Based on aggregated 13F filings for Q2 2020.